Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CHAT | P28329 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.37 |
| ▸ | CASP6 | P55212 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.35 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | CTSB | P07858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4519234 | 0.77 | TSHR (0.44) | ACACBALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL4519084 | 0.75 | ERN1 (0.45) | — | |
| SCHEMBL32681308 | 0.74 | ERN1 (0.40) | ALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL4524383 | 0.74 | PDK1 (0.33) | ALDH1A1MEN1KMT2ATSHRTDP1 | |
| SCHEMBL4520641 | 0.74 | P2RY6 (0.40) | ALDH1A1TSHR | |
| SCHEMBL4512933 | 0.73 | HCRTR1 (0.37) | ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL4519930 | 0.72 | FFAR1 (0.42) | ALDH1A1MEN1KMT2A | |
| SCHEMBL12920718 | 0.71 | CASP6 (0.47) | ALDH1A1MEN1KMT2AHPRT1CASP6 | |
| SCHEMBL4531614 | 0.69 | FFAR1 (0.39) | MEN1KMT2A | |
| SCHEMBL4525918 | 0.69 | MAPT (0.39) | ALDH1A1TDP1CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7566773-B2 | Photolabile compound and substrate for oligomer probe array with the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-07-28 | — | — | US | disclosed |
| US-20080057489-A1 | Photolabile Compound and Substrate for Oligomer Probe Array with the Same | SAMSUNG ELECTRONICS CO., LTD (KR) | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080057489-A1 | Photolabile Compound and Substrate for Oligomer Probe Array with the Same | APBA1, B3GNT2, PCNA | ACACB 244/4885ALDH1A1 825/4885CHAT 778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.